国际麻醉学与复苏杂志   2013, Issue (6): 9-9
    
注射用血凝酶术前给药对低分子肝素抗凝患者髋关节置换术围术期出血量及凝血功能的影响
王丹, 李艳辉, 麻海春1()
1.吉林大学第一医院
Effects of hemocoagulase on perioperative blood loss and coagulation in patients with low molecular heparin anticoagulation undergoing total hip replacement
 全文:
摘要:

【摘要】 目的 评价注射用血凝酶术前给药对低分子肝素抗凝患者髋关节置换术围术期出血量及凝血功能的影响。 方法 本试验为随机、对照、单盲的临床研究。择期全麻下单侧髋关节置换术患者40例,ASA分级为I或II级,年龄60~75岁,体重45~75 kg。术前1 d皮下注射低分子肝素(LMWH)4000单位,采用随机数字表法,将患者随机分为2组(n=20):注射用血凝酶组(H组)和生理盐水组(C组)。切皮前10 min,H组静脉给予注射用血凝酶2单位(5 ml生理盐水稀释),C组静脉注射等量生理盐水。记录术中出血量及术后24 h引流量,记录术毕及术后24 h凝血功能的各项指标。术后第5 d通过下肢深静脉彩超观察下肢深静脉血栓形成的发生情况。结果 与C组比较,H组术中出血量及术后24 h引流量减少﹙P<0.05﹚。与术前相比,两组术毕、术后24 h Hb、RBC、Hct分别减少(P<0.05)。与术前比较,两组术毕及术后24 h凝血常规各项指标差异无统计学意义(P>0.05)。两组术后深静脉血栓形成发生率差异无统计学意义(P>0.05)。结论 注射用血凝酶术前给药能减少低分子肝素抗凝下髋关节置换术患者围术期出血量,并不影响患者的凝血功能。

关键词: 注射用血凝酶;凝血功能试验;手术中并发症,手术后并发症;关节成形术,置换,髋;肝素,低分子量
Abstract:

【Abstract】 Objective To investigate the effects of hemocoagulase on perioperative blood loss and coagulation in patients with low molecular heparin(LMWH) anticoagulation undergoing total hip replacement(THR). Methods Forty ASA I or II patients aged 60-75 yr scheduled for total hip replacement were randomly divided into two groups( n = 20 each). The forty patients received LMWH for 4000 IU im 1 d preoperatively. 10 min before incision, Group H received hemocoagulase for 2 IU iv and group C received Normal Saline for 5 ml iv. The intraoperative and postoperative 24 h bleeding volume was measured respectively; meanwhile, the coagulation parameters were measured immediately, 24 h after operation respectively. We examined the deep vein thrombosis through CDFI 5 d after operation. Results The intraoperative and postoperative 24 h bleeding volume in Group H were less than Group C (P<0.05). In both groups, Hb, RBC, Hct immediately and 24 h after operation were significantly lower than preoperation (P<0.05). In both groups, APTT, PT, Fib immediately and 24 h after operation were same to preoperation (P>0.05).In both groups, there was no difference in the rate of deep venous thrombosis(P>0.05). Conclusion Perioperative bleeding volume can be reduced by intravenous injecting hemocoagulase preoperatively, and the coagulation can not be influenced.

Key words: Batroxobin; Blood coagulation tests;Intraoperative complications,postoperative complications;Arthroplasty, replacement, hip; Heparin, low-molecular-weight